2010
DOI: 10.1016/j.jaad.2009.09.048
|View full text |Cite
|
Sign up to set email alerts
|

Intralesional chemotherapy for nonmelanoma skin cancer: A practical review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
79
1
4

Year Published

2012
2012
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 88 publications
(91 citation statements)
references
References 50 publications
(114 reference statements)
1
79
1
4
Order By: Relevance
“…In this clinical scenario, a reasonable treatment approach for the eruptive keratoacanthomas is acitretin combined with intralesional chemotherapy. This treatment combination has been successful in multiple patients, [3][4][5][6] including the present case. …”
Section: Discussionsupporting
confidence: 54%
See 1 more Smart Citation
“…In this clinical scenario, a reasonable treatment approach for the eruptive keratoacanthomas is acitretin combined with intralesional chemotherapy. This treatment combination has been successful in multiple patients, [3][4][5][6] including the present case. …”
Section: Discussionsupporting
confidence: 54%
“…2,3 We report a patient with a history of multiple keratoacanthomas not associated with Ferguson-Smith disease who underwent radiation treatment for a large KCM. The primary tumor resolved completely, but the patient subsequently erupted with multiple keratoacanthomas within the well-defined field of radiation treatment.…”
Section: Introductionmentioning
confidence: 99%
“…5 Although used clinically for squamous cell carcinoma of the skin, there is little published evidence to support its use for this indication. 4,10 Methotrexate toxicity seems to be more common in patients with renal impairment, despite the low doses used intralesionally. Goebeler et al 11 reported pancytopenia, stomatitis, and bleeding in a 69-year-old man who was receiving hemodialysis and was treated with methotrexate 12.5 mg intralesionally for keratoacanthoma of the nose.…”
Section: Discussionmentioning
confidence: 99%
“…2012; 69:578-82ion are limited to case reports and case series [3][4][5]. Furthermore, little is known about the removal of methotrexate by peritoneal dialysis 6.…”
mentioning
confidence: 99%
“…Alternative therapies include electrodessication and curettage, intralesional pharmacologic therapy, ionizing radiation, and topical agents, but all these lack the histopathologic confirmation of the tumor. Intralesional therapy with 5-FU (50 mg/mL) is administered on a weekly basis for three to eight treatment sessions [6]. Intralesional injection of 1 mL of methotrexate in a concentration of 12.5 or 25 mg/ml every two to three weeks for one to four treatment sessions.…”
mentioning
confidence: 99%